198 related articles for article (PubMed ID: 33788143)
21. Hematopoietic stem cell transplantation for HIV cure.
Kuritzkes DR
J Clin Invest; 2016 Feb; 126(2):432-7. PubMed ID: 26731468
[TBL] [Abstract][Full Text] [Related]
22. The clinical applications of genome editing in HIV.
Wang CX; Cannon PM
Blood; 2016 May; 127(21):2546-52. PubMed ID: 27053530
[TBL] [Abstract][Full Text] [Related]
23. Designer Nucleases: Gene-Editing Therapies using CCR5 as an Emerging Target in HIV.
Almeida MJ; Matos A
Curr HIV Res; 2019; 17(5):306-323. PubMed ID: 31652113
[TBL] [Abstract][Full Text] [Related]
24. Autologous Hematopoietic Stem Cells transplantation and genetic modification of CCR5 m303/m303 mutant patient for HIV/AIDS.
Esmaeilzadeh A; Farshbaf A; Erfanmanesh M
Med Hypotheses; 2015 Mar; 84(3):216-8. PubMed ID: 25613565
[TBL] [Abstract][Full Text] [Related]
25. CCR5 Promoter Polymorphism -2459G > A: Forgotten or Ignored?
Mehlotra RK
Cells; 2019 Jun; 8(7):. PubMed ID: 31261839
[TBL] [Abstract][Full Text] [Related]
26. Combining Cell-Intrinsic and -Extrinsic Resistance to HIV-1 By Engineering Hematopoietic Stem Cells for CCR5 Knockout and B Cell Secretion of Therapeutic Antibodies.
Feist WN; Luna SE; Ben-Efraim K; Filsinger Interrante MV; Amorin NA; Johnston NM; Bruun TUJ; Ghanim HY; Lesch BJ; Dudek AM; Porteus MH
bioRxiv; 2024 Mar; ():. PubMed ID: 38496600
[TBL] [Abstract][Full Text] [Related]
27. Experimental Treatment of SIV-Infected Macaques via Autograft of
Yu S; Ou Y; Xiao H; Li J; Adah D; Liu S; Zhao S; Qin L; Yao Y; Chen X
Mol Ther Methods Clin Dev; 2020 Jun; 17():520-531. PubMed ID: 32258215
[TBL] [Abstract][Full Text] [Related]
28. Editing CCR5: a novel approach to HIV gene therapy.
Cornu TI; Mussolino C; Bloom K; Cathomen T
Adv Exp Med Biol; 2015; 848():117-30. PubMed ID: 25757618
[TBL] [Abstract][Full Text] [Related]
29. CCR5 as a natural and modulated target for inhibition of HIV.
Burke BP; Boyd MP; Impey H; Breton LR; Bartlett JS; Symonds GP; Hütter G
Viruses; 2013 Dec; 6(1):54-68. PubMed ID: 24381033
[TBL] [Abstract][Full Text] [Related]
30. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.
Hütter G; Nowak D; Mossner M; Ganepola S; Müssig A; Allers K; Schneider T; Hofmann J; Kücherer C; Blau O; Blau IW; Hofmann WK; Thiel E
N Engl J Med; 2009 Feb; 360(7):692-8. PubMed ID: 19213682
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation.
Nat Med; 2023 Mar; 29(3):547-548. PubMed ID: 36849733
[No Abstract] [Full Text] [Related]
32. Combinatorial Strategies for Long-term Control of HIV Infection.
Kwon D; Han MJ; Seo KW; Kang KS
AIDS Rev; 2020 Dec; 22(4):175-182. PubMed ID: 33401284
[TBL] [Abstract][Full Text] [Related]
33. CCR5-edited gene therapies for HIV cure: Closing the door to viral entry.
Haworth KG; Peterson CW; Kiem HP
Cytotherapy; 2017 Nov; 19(11):1325-1338. PubMed ID: 28751153
[TBL] [Abstract][Full Text] [Related]
34. Cord blood transplantation for cure of HIV infections.
Petz L
Stem Cells Transl Med; 2013 Sep; 2(9):635-7. PubMed ID: 23884642
[TBL] [Abstract][Full Text] [Related]
35. Coreceptor-Based Hematopoietic Stem Cell Gene Therapy for HIV Disease.
Hu J; Feng Y; Ma P; Lai Y
Curr Stem Cell Res Ther; 2019; 14(7):591-597. PubMed ID: 31120000
[TBL] [Abstract][Full Text] [Related]
36. Genetically modified hematopoietic stem cell transplantation for HIV-1-infected patients: can we achieve a cure?
Younan P; Kowalski J; Kiem HP
Mol Ther; 2014 Feb; 22(2):257-264. PubMed ID: 24220323
[TBL] [Abstract][Full Text] [Related]
37. Frequencies of gene variant CCR5-Δ32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers.
Solloch UV; Lang K; Lange V; Böhme I; Schmidt AH; Sauter J
Hum Immunol; 2017 Nov; 78(11-12):710-717. PubMed ID: 28987960
[TBL] [Abstract][Full Text] [Related]
38. Eradication of HIV by transplantation of CCR5-deficient hematopoietic stem cells.
Hütter G; Ganepola S
ScientificWorldJournal; 2011 May; 11():1068-76. PubMed ID: 21552772
[TBL] [Abstract][Full Text] [Related]
39. A mathematical model of HIV dynamics treated with a population of gene-edited haematopoietic progenitor cells exhibiting threshold phenomenon.
Ratti V; Nanda S; Eszterhas SK; Howell AL; Wallace DI
Math Med Biol; 2020 May; 37(2):212-242. PubMed ID: 31265056
[TBL] [Abstract][Full Text] [Related]
40. Combination gene therapy for HIV using a conditional suicidal gene with CCR5 knockout.
Mehmetoglu-Gurbuz T; Yeh R; Garg H; Joshi A
Virol J; 2021 Jan; 18(1):31. PubMed ID: 33516234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
